The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2024

Filed:

Sep. 20, 2018
Applicant:

Spogen Biotech Inc., St. Louis, MO (US);

Inventors:

Brian M. Thompson, Creve Coeur, MO (US);

Jorg Augustin, Chesterfield, MO (US);

Ashley Siegel, St. Louis, MO (US);

Assignee:

Spogen Biotech Inc., St. Louis, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/78 (2006.01); A01N 63/22 (2020.01); A23K 10/18 (2016.01); A23K 20/189 (2016.01); A61K 9/00 (2006.01); A61K 35/742 (2015.01); A61K 38/00 (2006.01); C07K 14/32 (2006.01); C12N 9/24 (2006.01); C12N 9/42 (2006.01);
U.S. Cl.
CPC ...
C12N 9/78 (2013.01); A01N 63/22 (2020.01); A23K 10/18 (2016.05); A23K 20/189 (2016.05); A61K 9/0056 (2013.01); A61K 35/742 (2013.01); C07K 14/32 (2013.01); C12N 9/2402 (2013.01); C12N 9/2434 (2013.01); C12Y 302/01151 (2013.01); C12Y 305/99007 (2013.01); A61K 38/00 (2013.01); C07K 2319/035 (2013.01);
Abstract

Fusion proteins containing a targeting sequence, exosporium protein, or exosporium protein fragment that targets the fusion protein to the exosporium of a recombinantfamily member are provided. The fusion proteins further comprise an enzyme having ACC deaminase activity, a phospholipase, a lipase, a xylanase, a xylosidase, a lactonase, a chitosanase, a protease, a glucanase, a phytase, an acid phosphatase, a pectinase, a mannanase, and/or an expansin protein. Also provided are recombinantfamily members that express the fusion proteins, exosporium fragments derived from the recombinantfamily members, and formulations containing the recombinantfamily members or exosporium fragments. Plant seeds treated with the recombinantfamily members, exosporium fragments, or formulations are also provided. The invention further relates to methods for stimulating plant growth and/or promoting plant health using the recombinantfamily members, exosporium fragments, or formulations.


Find Patent Forward Citations

Loading…